Three studies offer reassuring news that adverse kidney changes that accompany Truvada use for PrEP are rarely serious and universally reverse after stopping the medication, but also that older people and those with the best adherence might need to b...
Research presented at CROI 2016 shows that Truvada PrEP is safe for most people, but impaired kidney function -- usually mild or moderate -- may occur in a small proportion of people on PrEP, especially if they have other risk factors.
In people with initially normal kidney function, each additional year taking tenofovir disoproxil fumarate (TDF, Viread), ritonavir (Norvir)-boosted atazanavir (Reyataz) or lopinavir/ritonavir (Kaletra) raised the risk of chronic kidney disease (CKD)...
In general, tenofovir alafenamide (TAF) is safe, with improvements in bone and kidney health over tenofovir disoproxil fumarate (TDF). However, those with severe kidney disease may not see improvements in kidney health, according to a recent study....
A new single-tablet HIV regimen containing tenofovir alafenamide (TAF) offered better bone and kidney safety, according to a study presented at ICAAC/ICC 2015.
The new formulation of tenofovir, tenofovir alafenamide (TAF), was associated with less harm to bones and kidneys than the older formulation, tenofovir disoproxil fumarate (TDF, Viread).
Renal dysfunction was more likely in patients who had taken tenofovir (Truvada, TDF) longer, were older, or also had diabetes or hypertension, according to a study presented at IDWeek 2014.
Study finds cobicistat-containing regimens are effective and well-tolerated by HIV-infected patients with mild to moderate renal impairment.
Taking Truvada (tenofovir/emtricitabine) as pre-exposure prophylaxis (PrEP) has little effect on kidney function, according to a new study.
Someone diagnosed with HIV nowadays -- who is quickly put on ART -- can live a near-normal lifespan, but many organs, like the kidneys, are affected by HIV and need monitoring.